Advanced

Phoxilium® reduces hypophosphataemia and magnesium supplementation during continuous renal replacement therapy

Godaly, Gabriela LU ; Carlsson, Ola LU and Broman, Marcus (2016) In Clinical Kidney Journal 9(2). p.205-210
Abstract

Background Although associated with severe clinical complications, phosphate remains a neglected ion. Additionally, phosphate balance during continuous renal replacement therapy (CRRT) is complex and multifunctional. The present retrospective study investigated the effects of phosphate-containing CRRT fluid on phosphate homeostasis. Methods We retrospectively analysed 112 patients treated with CRRT at Skane University Hospital, Sweden. The control group was treated with Hemosol® B0 (no phosphate; n = 36) as dialysis and replacement fluid, while the study group received Phoxilium® (phosphate; n = 76) as dialysis fluid and Hemosol® B0 as replacement fluid. Results Hypophosphataemia (

Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
critically ill patients, CRRT, hypophosphataemia, intensive care medicine
in
Clinical Kidney Journal
volume
9
issue
2
pages
6 pages
publisher
Oxford University Press
external identifiers
  • Scopus:84963946824
ISSN
2048-8505
DOI
10.1093/ckj/sfv133
language
English
LU publication?
yes
id
d9a36a3d-8e11-4070-bd86-cbd3135a44ea
date added to LUP
2016-06-16 09:07:45
date last changed
2016-10-07 15:20:22
@misc{d9a36a3d-8e11-4070-bd86-cbd3135a44ea,
  abstract     = {<p>Background Although associated with severe clinical complications, phosphate remains a neglected ion. Additionally, phosphate balance during continuous renal replacement therapy (CRRT) is complex and multifunctional. The present retrospective study investigated the effects of phosphate-containing CRRT fluid on phosphate homeostasis. Methods We retrospectively analysed 112 patients treated with CRRT at Skane University Hospital, Sweden. The control group was treated with Hemosol® B0 (no phosphate; n = 36) as dialysis and replacement fluid, while the study group received Phoxilium® (phosphate; n = 76) as dialysis fluid and Hemosol® B0 as replacement fluid. Results Hypophosphataemia (</p>},
  author       = {Godaly, Gabriela and Carlsson, Ola and Broman, Marcus},
  issn         = {2048-8505},
  keyword      = {critically ill patients,CRRT,hypophosphataemia,intensive care medicine},
  language     = {eng},
  month        = {04},
  number       = {2},
  pages        = {205--210},
  publisher    = {ARRAY(0xb0765c8)},
  series       = {Clinical Kidney Journal},
  title        = {Phoxilium® reduces hypophosphataemia and magnesium supplementation during continuous renal replacement therapy},
  url          = {http://dx.doi.org/10.1093/ckj/sfv133},
  volume       = {9},
  year         = {2016},
}